Efforts to regulate pharmacy benefit managers (PBMs) are facing resistance despite bipartisan support for overhauling their practices. The pharmaceutical industry's lobbying has stalled legislation to increase transparency and control costs. Lawmakers fear rising premiums and prices due to PBM lobbying.